Alzheimer clinical trial

IGC Pharma Inc (NYSE:IGC) witnessed a surge of 69.40%  in its stock value during after-hours trading on Wednesday. What Happened: The stock of IGC Pharma, a company involved in the development of cannabinoid-based therapies for Alzheimer‘s disease, rose by 69.40% to $0.62. This surge...